Thermo Fisher Scientific Inc. raised its revenue forecast after stronger-than-expected spending by biotech and pharma customers and a rebound in laboratory instrument demand helped pushed second-quarter sales past expectations. Shares jumped.
Thermo Fisher Scientific Inc. raised its revenue forecast after stronger-than-expected spending by biotech and pharma customers and a rebound in laboratory instrument demand helped pushed second-quarter sales past expectations. Shares jumped.
<iframe src="https://statesidedaily.com/embed/cluster/45cb11ee2f60d02d1dd7bf8f82b9634a1831b678" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Thermo Fisher Rises as Instrument Demand Recovery Lifts Outlook"></iframe>
